Curcumin therapy in inflammatory bowel disease: a pilot study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16240238
Conclusion of this study
A pure curcumin preparation was administered in an open label study to five patients with ulcerative proctitis and five with Crohn's disease. All proctitis patients improved, with reductions in concomitant medications in four, and four of five Crohn's disease patients had lowered CDAI scores and sedimentation rates. This encouraging pilot study suggests the need for double-blind placebo-controlled follow-up studies.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study